Loading data
ROIVNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 8.26 m USD | 29.05 m USD | 32.71 m USD | 31.53 m USD | 55.29 m USD |
| Research and development expense | 681.81 m USD | 550.41 m USD | 439.91 m USD | 454.06 m USD | 483.04 m USD |
| Selling, general and administrative expense | — | — | 687.44 m USD | 600.51 m USD | 775.03 m USD |
| Operating profit | -515.07 m USD | -1 bn USD | 4.5 bn USD | -906.76 m USD | -1.35 bn USD |
| Interest expense | — | — | 34.78 m USD | 27.97 m USD | 7.04 m USD |
| Profit before tax | -264.58 m USD | -681.59 m USD | 4.57 bn USD | -884.99 m USD | -923.75 m USD |
| Income tax expense | 133.33 m USD | 48.17 m USD | 21.5 m USD | 4.08 m USD | 369 k USD |
| Net income (reported basis) | -299.77 m USD | -171.98 m USD | 4.35 bn USD | -1.01 bn USD | -845.26 m USD |
| Net income attributable to common shareholders | -299.77 m USD | -171.98 m USD | 4.35 bn USD | — | — |
| Basic earnings per share | -0.43 USD/share | -0.24 USD/share | 5.55 USD/share | -1.42 USD/share | -1.26 USD/share |
| Diluted earnings per share | -0.54 USD/share | -0.24 USD/share | 5.23 USD/share | -1.42 USD/share | -1.26 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.